Grace Therapeutics Email Format
Pharmaceutical ManufacturingNew Jersey, United States2-10 Employees
Grace Therapeutics is a small specialty pharmaceutical company focused on rare and orphan diseases, based in East Brunswick, New Jersey. It aims to improve outcomes for drugs already approved for human use by developing delivery technologies, guided by an evidence-based, outcomes-driven approach. Its late-stage pipeline comprises three assets targeting Postherpetic Neuralgia, Subarachnoid Hemorrhage, and Ataxia Telangiectasia, and the company plans to pursue multiple commercialization options that leverage its platform technologies. Its leadership blends drug-delivery science expertise with commercial experience and a track record of translating research to patient care. In 2021, Grace Therapeutics was acquired by Acasti Pharma Inc. through a merger. The organization operates with a small team.